A precise and non-toxic treatment that targets lung cancer cells at the nanoscale is able to effectively kill the cells even at a low dose.
Researchers from Washington State University and the Department of Energy’s Pacific Northwest National Laboratory (PNNL) used tiny tubes made from organic molecules called peptoids to deliver cancer-killing drugs in a targeted manner. The research, led by Yuehe Lin, professor in WSU’s School of Mechanical and Materials Engineering, and Chun-Long Chen, a senior research scientist at PNNL and a joint faculty fellow at the University of Washington, was published as the cover story in the prestigious journal Small.
The biologically-inspired nanotubes, which are about a hundred thousand times thinner than a human hair, were rolled up from membrane-like nanosheets. The drug molecules, fluorescent dyes and cancer-targeting molecules were precisely placed within the nanotubes, enabling them to track the efficiency of drug delivery into the cancer cells.
The new technology allows the two drugs – one for chemotherapy and the other for a less-invasive photodynamic therapy treatment – to be delivered directly to the cancer cells. Photodynamic therapy uses a chemical that, when exposed to light, releases reactive oxygen species (ROS) that kill cancer cells. The researchers’ dual-drug approach enabled the use of a lower dose of the cancer drugs than using a single drug, leading to effective killing of cancer cells with low toxicity.
“By precisely engineering these nanotubes with fluorescent dyes and cancer targeting molecules, scientists can clearly locate tumor cells and track how the drug regimen is performing,” said Lin. “We can also track how nanotubes enter and deliver the drugs inside the cancer cell.”
The team tested the nanotubes on lung cancer cells and found that they delivered the chemotherapy drug doxorubicin directly into the fast-dividing cancer cells, resulting in highly efficient cancer killing while using less chemotherapy drugs.
“This is a promising approach for precision targeting with little damage to healthy surrounding cells,” said Lin.
While other nanomaterials, such as carbon nanotubes, have been used to deliver and track cancer-killing drugs, researchers have found that they are toxic to the body. Furthermore, they didn’t do well at precisely recognizing molecules.
“By using these peptoids, we were able to develop highly programmable nanotubes and a biocompatible delivery mechanism,” said Chen. “We also harnessed the high stability of peptoid and its well-controlled packing to develop nanotubes that are highly stable.”
“Due to their unique structure, these nanotubes can be easily assembled for use in cancer therapy and stay in the body longer for treatment,” said Lin.
The team is now looking for collaboration and funding opportunities with pharmaceutical companies to extend the research into animal and clinical studies.
The Latest on: Lung cancer
via Google News
The Latest on: Lung cancer
- Common TB vaccine associated with lower lung cancer rates on November 18, 2019 at 10:22 am
(HealthDay)—Childhood vaccination with the bacille Calmette-Guérin (BCG) vaccine is associated with a reduced risk for lung cancer, according to a study published online Sept. 25 in JAMA Network Open.
- Reducing your risk of lung cancer on November 18, 2019 at 8:25 am
GRAND RAPIDS, Mich. (WOOD) – November is Lung Cancer Awareness Month and with lung cancer being the leading cancer death among both men and women, it’s important to know the signs, symptoms and how ...
- My Nagging Cough Turned Out to Be Lung Cancer on November 18, 2019 at 8:25 am
In my case, that’s when things hit the fan and they told me I had lung cancer. By then it was January 2016, so the whole process, from the initial coughing to diagnosis, took about three months. There ...
- Smoke in the Past? Boosting Your Fitness Now Can Cut Your Lung Cancer Risk on November 18, 2019 at 6:22 am
Former smokers with high levels of fitness are less likely to develop lung cancer than those who are not as fit, according to a new study published in the American Journal of Preventive Medicine.
- The Woman's Doctor: Lung cancer in non-smokers on November 18, 2019 at 5:17 am
THE DEVELOPMENT OF THE WOMEN'S LUNGS AND THEIR ABILITY, THEIR SMALLER AIRWAYS, TO CLEAR OUT NOXIOUS SUBSTANCES THEY'RE EXPOSED TO. THE SAME THING THAT CAUSES COPD, SAME THING FOR LUNG CANCER. THEY'RE ...
- Gloucester couple both diagnosed with lung cancer 5 weeks apart on November 18, 2019 at 2:35 am
GLOUCESTER, Va. (WAVY) — A Gloucester couple is in the fight of their lives, together. During Lung Cancer Awareness Month, they have a story to share and a reminder for others. Lisa and Seth Doyle ...
- Lung Cancer Drugs Market Size, Growth Outlook 2019-2025, Demand, Evolving Technology, Boost Efficiency, Top Companies on November 17, 2019 at 10:31 pm
Nov 18, 2019 (AmericaNewsHour) -- Global Lung Cancer Drugs Market - Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025 [93 pages report] This market research report includes a ...
- Lung Cancer Therapeutics Market Size, Share, Opportunities, Development and Global Trend Analysis till 2026 - MarketWatch on November 17, 2019 at 10:00 pm
Nov 18, 2019 (The Expresswire) -- Lung Cancer Therapeutics Market: How the Business Will Grow in 2025? Prominent Players: Astellas Pharma US, Celgene, Merck Sharp & Dohme GmbH, Pfizer, Eli Lilly and ...
- Clinical Challenges: Small Cell Lung Cancer on November 15, 2019 at 11:18 am
Small cell lung cancer (SCLC) is a cancer subtype for which there has long been a dearth of effective treatment options. "For 35 years nothing has really worked in small cell lung cancer," said Julian ...
- Simple Cough Could Be A Warning Symptom Of The Deadly Lung Cancer on November 15, 2019 at 3:50 am
Lung cancer is among the most common yet severe types of cancer in the modern world. According to official data, approximately 47,000 people in the UK are diagnosed with lung cancer every year. The ...
via Bing News